| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |